DE69709933T2 - Aromatische amidinderivate als selektive thrombininhibitoren - Google Patents

Aromatische amidinderivate als selektive thrombininhibitoren

Info

Publication number
DE69709933T2
DE69709933T2 DE69709933T DE69709933T DE69709933T2 DE 69709933 T2 DE69709933 T2 DE 69709933T2 DE 69709933 T DE69709933 T DE 69709933T DE 69709933 T DE69709933 T DE 69709933T DE 69709933 T2 DE69709933 T2 DE 69709933T2
Authority
DE
Germany
Prior art keywords
selective
aromatic amidine
amidine derivatives
thrombine
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69709933T
Other languages
English (en)
Other versions
DE69709933D1 (en
Inventor
Am Koo
Ki Min
Sang Hong
Jung Ryu
Hyun Nam
Min Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C & C Res Lab Kyunggi
Original Assignee
C & C Res Lab Kyunggi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C & C Res Lab Kyunggi filed Critical C & C Res Lab Kyunggi
Publication of DE69709933D1 publication Critical patent/DE69709933D1/de
Application granted granted Critical
Publication of DE69709933T2 publication Critical patent/DE69709933T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69709933T 1996-05-31 1997-05-31 Aromatische amidinderivate als selektive thrombininhibitoren Expired - Fee Related DE69709933T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19960019282 1996-05-31
PCT/KR1997/000100 WO1997045424A1 (en) 1996-05-31 1997-05-31 Aromatic amidine derivatives useful as selective thrombin inhibitors

Publications (2)

Publication Number Publication Date
DE69709933D1 DE69709933D1 (en) 2002-02-28
DE69709933T2 true DE69709933T2 (de) 2002-08-29

Family

ID=19460481

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69709933T Expired - Fee Related DE69709933T2 (de) 1996-05-31 1997-05-31 Aromatische amidinderivate als selektive thrombininhibitoren

Country Status (11)

Country Link
US (1) US6201006B1 (de)
EP (1) EP0918768B1 (de)
JP (1) JP3202994B2 (de)
KR (1) KR100469028B1 (de)
CN (1) CN1079396C (de)
AT (1) ATE211741T1 (de)
AU (1) AU3049497A (de)
CA (1) CA2256438C (de)
DE (1) DE69709933T2 (de)
ES (1) ES2171945T3 (de)
WO (1) WO1997045424A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602864B1 (en) * 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
KR19990043605A (ko) * 1997-11-29 1999-06-15 이경하 선택적 트롬빈 억제제로 유용한 방향족 아미딘유도체
SK15072000A3 (sk) 1998-04-10 2001-08-06 Japan Tobacco Inc. Amidové zlúčeniny
WO2000073269A2 (en) * 1999-06-02 2000-12-07 Regents Of The University Of Minnesota Nicotine receptor ligands
WO2001014358A2 (en) * 1999-08-26 2001-03-01 Aventis Pharmaceuticals Inc. Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
GB9924155D0 (en) * 1999-10-12 1999-12-15 Rhone Poulenc Rorer Pharma Chemical compounds
US7361663B2 (en) * 1999-11-10 2008-04-22 Aventis Pharmaceuticals Inc. N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
IL149544A0 (en) * 1999-11-10 2002-11-10 Aventis Pharma Gmbh N-ACYLPYRROLIDIN-2-YLALKYLBENZAMIDINE DERIVATIVES AS INHIBITORS OF FACTOR Xa
WO2004103993A1 (en) * 2003-05-14 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
JP2005350417A (ja) * 2004-06-11 2005-12-22 Dai Ichi Seiyaku Co Ltd 還元的エーテル化法を用いたピロリジン誘導体の製造法
WO2006038119A1 (en) * 2004-10-08 2006-04-13 Warner-Lambert Company Llc Stereoselective synthesis of n-protected alkoxy prolines
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2007143211A2 (en) * 2006-06-02 2007-12-13 Bioseek, Inc. Methods for identifying agents and their use for the prevention of restenosis
EP2085397A1 (de) * 2008-01-21 2009-08-05 Esteve Quimica, S.A. Kristalline Form von Abacavir
SG194901A1 (en) 2011-05-09 2013-12-30 Univ Glasgow Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
CN113956192A (zh) * 2021-11-16 2022-01-21 上海延安药业（湖北）有限公司 一种阿维巴坦中间体的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258192A (en) * 1977-12-16 1981-03-24 Mitsubishi Chemical Industries Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
JPS5813549A (ja) * 1981-07-15 1983-01-26 Kowa Co 新規フエニルエステル類
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JPH0820532A (ja) * 1994-07-05 1996-01-23 Dai Ichi Seiyaku Co Ltd 抗膵炎剤

Also Published As

Publication number Publication date
DE69709933D1 (en) 2002-02-28
CA2256438A1 (en) 1997-12-04
JP2000504030A (ja) 2000-04-04
CA2256438C (en) 2002-10-15
US6201006B1 (en) 2001-03-13
EP0918768A1 (de) 1999-06-02
ES2171945T3 (es) 2002-09-16
WO1997045424A1 (en) 1997-12-04
KR970074779A (ko) 1997-12-10
CN1219932A (zh) 1999-06-16
CN1079396C (zh) 2002-02-20
EP0918768B1 (de) 2002-01-09
ATE211741T1 (de) 2002-01-15
AU3049497A (en) 1998-01-05
JP3202994B2 (ja) 2001-08-27
KR100469028B1 (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
DE69709933T2 (de) Aromatische amidinderivate als selektive thrombininhibitoren
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
IL156873A0 (en) Pharmaceutically active piperidine derivatives
NO983376L (no) Sulfonerte aminosyrederivater og metalloproteinase inhibitorer inneholdende de samme
MX9704439A (es) Derivados heterociclicos aromaticos como inhibidores de enzima.
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
DK1001930T3 (da) N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser
DE60120881D1 (de) Sulfonamide als matrix-metalloproteinase inhibitoren
BR9810459A (pt) sais nìtricos dos inibidores de ace
NO20004531L (no) Halogenerte amidinoaminosyre-derivater anvendbare som nitrogenoksid syntase inhibitorer
TR200103099T2 (tr) Fosfodiesteraz IVinhibitörü 1-amino triazoloc 4,3-a!kinazolin-5-on ve/veya-5-tionlar
BR0115318A (pt) Derivados de (diidro)isoquinolina como inibidores da fosfodiesterase
NO983992L (no) Serinprotease inhibitorer
DK0941221T3 (da) Substituerede dihydrobenzofuraner som PDE-inhibitorer
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
BR0315662A (pt) Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona
TR200001452T2 (tr) Bifenilamidin türevleri.
NO985891L (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
ATE253359T1 (de) Antithrombotische mittel
NO20015892L (no) Inhibitorer av metallproteinaser
DK0880520T3 (da) Benzo[c]quinolinderivater, deres fremstilling af anvendelse som 5-alfa-reduktaseinhibitorer
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee